Multi-residue determination of non-steroidal anti-inflammatory drug residues in animal serum and plasma by HPLC and photo-diode array detection

Journal of Chromatographic Science

Volumn 44, Issue 10, 2006, Pages 585-590

  Gallo, Pasquale ^a   Fabbrocino, Serena ^a   Vinci, Floriana ^a   Fiori, Maurizio ^b   Danese, Vincenzo ^b   Nasi, Antonella ^a   Serpe, Luigi ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DEL MEZZOGIORNO   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

DRUG RESIDUE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; BLOOD; CATTLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; METHODOLOGY; PHOTOCHEMISTRY; REPRODUCIBILITY; SWINE; VALIDATION STUDY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; HORSES; PHOTOCHEMISTRY; REPRODUCIBILITY OF RESULTS; SWINE;

EID: 33847768708     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/44.10.585     Document Type: Article

References (22)

1. N.H. Booth. Veterinary Pharmacology and Therapeutics. 5th Edition N.H. Booth and L.E. McDonalds (Eds), Iowa State University Press, Ames, IA, 297-320.
2. P.W. Lockwood, J.C. Johnson, and T.L. Katz. Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease. Veterinary Record. 152: 392-94 (2003).
3. A. Goodman Gilman, T.W. Rall, A.S. Nies, and P. Taylor. The Pharmacological Basis of Therapeutics. Vol. I, McGraw-Hill, Singapore, 1992, 638.
4. European Commission - Reference Laboratory for Residues of Veterinary Drugs. Workshop NSAIDs and Validation According to the SANCO 1805/2000, Berlin, Germany, 2001.
5. C. Kollias. Residues and considerations for use of pharmaceutics in the performance horse. Vet. Clin. North. Am. Equine Pract. 17(3): 433-44 (2001).
6. R. Hopes. Uses and misuses of anti-inflammatory drugs in racehorses. Equine Vet. J. 4(2): 66-68 (1972).
7. United States Food and Drug Administration. Freedom of Information Summary, NADA 140-958. US FDA, Washington, D.C. http://www.fda.gov/FOI/1342.htp.
8. United States Food and Drug Administration. Freedom of Information Summary, NADA 200-126, US FDA, Washington, D.C. http://www.fda.gov/cvm/FOI/3347. htp.
9. M. Kopcha, J.B. Kaneene, M.E. Shea, R. Miller, and S. Ahl. Use of non steroidal anti-inflammatory drugs in food animal practice. J. Am. Vet. Med. Assoc. 201: 1868-72 (1982).
10. F. Kari, J. Bucher, J. Haseman, S. Eustis, and H. Huff. Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Jpn. J. Cancer Res. 86: 252-63 (1995).
11. European Commission. Council Regulation 2377/90/EEC of 26 June 1990 laying down a community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Off J. Eur. Com. L224: 1-8 (1990).
12. European Commission. Council Regulation 434/97/EC of 3 March 1997 amending regulation (EEC) No 2377/90 laying down a community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. European Commission. Off J. Eur. Com. L67: 1-3 (1997).
13. E.J. Ian De Veau. Determination of phenylbutazone residues in bovine milk by liquid chromatography with UV detection. J AOAC Int. 79(5): 1050-53 (1996).
14. P. Gowik, B. Jülicher, and S. Uhlig. Multi-residue method for non-steroidal anti-inflammatory drugs in plasma using high performance liquid chromatography-photodiode array detection. Method description and comprehensive in-house validation. J. Chromatogr. B 716: 221-32 (1998).
15. S. Hines, J. Bright, and C. Pearce. "Screening and confirmatory residue analysis of non-steroidal anti-inflammatory drugs (NSAIDs) in bovine, porcine and equine liver by high performance liquid chromatography-fluorescence/ UV (HPLC-fluorescence and HPLC-UV) and gas chromatography-mass spectrometry (GC-MS)". Proceedings of the EuroResidue V - Conference on Residues of Veterinary Drugs in Foods. Noordwijkerhout, the Netherlands, 520-26 (2004).
16. S. Croubels, A. Maes, K. Baert, and P. De Baker. "Quantitative determination of salicylate and metabolites in animal tissues by LC-MS/MS". Proceedings of the EuroResidue V-Conference on Residues of Veterinary Drugs in Foods. Noordwijkerhout, the Netherlands, 416-21 2004.
17. C. Igualada and F. Moragues. "Determination of phenilbutazone and oxyphenbutazone in animal urine by ion-trap liquid chromatography-mass spectrometry". Proceedings of the EuroResidue V - Conference on Residues of Veterinary Drugs in Foods. Noordwijkerhout, the Netherlands, 562-67 (2004).
18. P.L. Boner, D.D. Liu, W.F. Feely, R.A. Robinson, and J. Wu. Determination of flunixin in edible bovine tissues using liquid chromatography coupled with tandem mass spectrometry. J. Agric. Food Chem. 51(26): 7555-59 (2003).
19. P.L. Boner, D.D. Liu, W.F. Feely, M.J. Wisocky, and J. Wu. Determination and confirmation of 5-hydroxyflunixin in raw bovine milk using liquid chromatography tandem mass. J. Agric. Food Chem. 51(13): 3753-59 (2003).
20. N. Van Hoof, K. De Wasch, S. Poelmans S., H. Noppe, and H. De Brabander. Multi-residue liquid chromatography/tandem mass spectrometry methods for the detection of non-steroidal antiinflammatory drugs in bovine muscle: optimisation of ion trap parameters. Rapid Comm. Mass Spectrom. 18(23): 2823-29 (2004).
21. S.B. Clark, S.B. Turnipseed, G.J. Nandrea, and M.R. Madson. Confirmation of phenylbutazone residues in bovine kidney by liquid chromatography/mass spectrometry. J. AOAC Int. 85(5): 1009-14 (2002).
22. European Commission Decision 2002/657/EC. Commission Decision implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Com. L221: 8-36 (2002).